1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Allogeneic HSCT: new trials by email Literature Review of Allogeneic HSCT trials Research Report on Allogeneic HSCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies Cytarabine, Busulfan, Cyclophosphamide - Leukemia, MDS | Phase 3 | Completed | First Affiliated Hospital of Zhejiang University | 232 | 2020-09-01 | 2026-11-18 |
| Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML Allogeneic HSCT, Anti-thymocyte globulin (ATG), Cyclosporine (CSP) - Leukemia, Myeloid, Leukemia | Phase 3 | Terminated | Stanford University | 58 | 2007-08-01 | 2019-09-24 |
Leukemia (2) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1)
First Affiliated Hospital of Zhejiang University (1) · Stanford University (1)
China (1) · United States (1)
Robert Lowsky (1) · Yi Luo, MD (1)